Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.
Blood. 2022 Feb 3;139(5):748-760. doi: 10.1182/blood.2021012976.
Blood. 2022.
PMID: 34587248
Free PMC article.